Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06133686
What this trial is testing

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa

Who this might be right for
HIV
MRC/UVRI and LSHTM Uganda Research Unit 400
Testing effectiveness (Phase 2)Study completedNCT02788045
What this trial is testing

Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 201
Testing effectiveness (Phase 2)UnknownNCT00791700
What this trial is testing

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 103
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Testing effectiveness (Phase 2)Study completedNCT00352911
What this trial is testing

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
VGX Pharmaceuticals, LLC 19
Not applicableStudy completedNCT00255840
What this trial is testing

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Who this might be right for
HIV Infections
CIPRA SA 812
Post-approval studies (Phase 4)Study completedNCT01348282
What this trial is testing

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

Who this might be right for
Neurocognitive DisturbanceHIV Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 33
Testing effectiveness (Phase 2)Study completedNCT00511368
What this trial is testing

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Who this might be right for
HIV Infections
Myrexis Inc. 92
Post-approval studies (Phase 4)Study completedNCT01900015
What this trial is testing

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Testing effectiveness (Phase 2)Study completedNCT02029430
What this trial is testing

Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Who this might be right for
Kaposi's SarcomaHIV PositiveAIDS
ImmunityBio, Inc. 15
Post-approval studies (Phase 4)Looking for participantsNCT07678268
What this trial is testing

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up

Who this might be right for
HIV InfectionAntiretroviral TherapyLentivirus Infections
Instituto Mexicano del Seguro Social 78
Post-approval studies (Phase 4)Study completedNCT00414635
What this trial is testing

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Who this might be right for
HIV Infections
Community Research Initiative of New England 60
Testing effectiveness (Phase 2)Study completedNCT00002435
What this trial is testing

Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia
Early research (Phase 1)Study completedNCT01071031
What this trial is testing

HIV Vaccine Study in HIV Positive Patients

Who this might be right for
HIV Infections
PepTcell Limited 54
Testing effectiveness (Phase 2)Study completedNCT00071851
What this trial is testing

Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT00355524
What this trial is testing

Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

Who this might be right for
HIV-1HIV Infections
Tibotec Pharmaceuticals, Ireland 80
Not applicableStudy completedNCT04902820
What this trial is testing

PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention

Who this might be right for
Pre-Exposure ProphylaxisHIVTelemedicine
ETR Associates 229
Large-scale testing (Phase 3)UnknownNCT00007436
What this trial is testing

The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences
Early research (Phase 1)WithdrawnNCT00068991
What this trial is testing

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00002224
What this trial is testing

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 120
Next Page